Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?
Diabetes mellitus
thyroid eye disease
thyroid-related orbitopathy
type-2 DM
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
To study the correlation between thyroid eye disease (TED) with type-2 diabetes mellitus. A cross-sectional cohort study was conducted from Jan 2018 to Dec 2018, in patients presenting with thyroid eye disease to orbit and oculoplasty clinic of a tertiary eye care hospital. A total of 105 patients were included in the study. All patients underwent detailed ophthalmic evaluation and thyroid eye disease workup. Patients were categorized into mild, moderate, and severe/sight-threatening TED based on EUGOGO classification. Systemic history of diabetes was noted. RBS was done in all patients. Mild disease was noted 61 patients of which 11 were diabetics, moderate in 26 patients (8 diabetics), and severe disease in 18 patients (14 diabetics). All patients were treated accordingly. Among the TED patients, the percentage of diabetic patients was noted to be in increasing order toward the severity spectrum of TED. The prevalence of severe TED was found to be much higher in diabetic patients accounting upto 77.77% of 18 patients. A statistically significant correlation was noted (P = 0.014) between severe TED and type-2 diabetes mellitus. In addition, early onset of thyroid eye disease was noted in type-2 diabetes patients. Even though female preponderance was noted, severe TED was more in men (66.6%). An autoimmune etiology for the association of thyroid and type-1diabetes has been well established. This study shows that type-2 diabetic patients can have more severity in the clinical presentation of TED. Therefore, the presence of type-2 DM in patients with TED can be a predictive factor for onset, progression, and severity of disease. Hence, a high concern of interest among treating ophthalmologists and endocrinologists regarding this entity would help in early prediction and decreased morbidity among such patients.
Identifiants
pubmed: 32461446
pii: IndianJOphthalmol_2020_68_6_1127_284783
doi: 10.4103/ijo.IJO_1443_19
pmc: PMC7508111
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1127-1131Déclaration de conflit d'intérêts
None
Références
Endocr Rev. 1993 Dec;14(6):747-93
pubmed: 8119236
Endocrinol Metab Clin North Am. 1987 Jun;16(2):391-407
pubmed: 3319588
Prim Care Diabetes. 2011 Dec;5(4):241-4
pubmed: 21704580
Ophthalmology. 1990 May;97(5):636-41
pubmed: 2342809
Br J Ophthalmol. 1999 Apr;83(4):463-5
pubmed: 10434871
Arch Intern Med. 2000 Jun 12;160(11):1573-5
pubmed: 10847249
Eur J Endocrinol. 2008 Mar;158(3):273-85
pubmed: 18299459
Eur Thyroid J. 2018 Mar;7(2):88-94
pubmed: 29594060
J Diabetes Res. 2013;2013:390534
pubmed: 23671867
Nutr Metab Cardiovasc Dis. 2015 May;25(5):452-7
pubmed: 25746910
Thyroid. 2010 Jul;20(7):777-83
pubmed: 20578901
Ophthalmology. 1988 Nov;95(11):1515-21
pubmed: 3211460
Eur J Endocrinol. 2018 Jun;178(6):635-643
pubmed: 29650691
Thyroid. 2008 Dec;18(12):1297-301
pubmed: 19012471